The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target

Alzheimer’s disease is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. However, emerging evidence suggests that neuroinflammation, mediated notably by activated neuroglial cells, neutrophils, and macrophages, also plays an important role in the pathogen...

Full description

Bibliographic Details
Main Authors: Marta Rusek, Joanna Smith, Kamel El-Khatib, Kennedy Aikins, Stanisław J. Czuczwar, Ryszard Pluta
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/1/864
_version_ 1797625556873773056
author Marta Rusek
Joanna Smith
Kamel El-Khatib
Kennedy Aikins
Stanisław J. Czuczwar
Ryszard Pluta
author_facet Marta Rusek
Joanna Smith
Kamel El-Khatib
Kennedy Aikins
Stanisław J. Czuczwar
Ryszard Pluta
author_sort Marta Rusek
collection DOAJ
description Alzheimer’s disease is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. However, emerging evidence suggests that neuroinflammation, mediated notably by activated neuroglial cells, neutrophils, and macrophages, also plays an important role in the pathogenesis of Alzheimer’s disease. Therefore, understanding the interplay between the nervous and immune systems might be the key to the prevention or delay of Alzheimer’s disease progression. One of the most important mechanisms determining gliogenic cell fate is the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway that is influenced by the overactivation of microglia and astrocytes. The JAK/STAT signaling pathway is one of the critical factors that promote neuroinflammation in neurodegenerative diseases such as Alzheimer’s disease by initiating innate immunity, orchestrating adaptive immune mechanisms, and finally, constraining neuroinflammatory response. Since a chronic neuroinflammatory environment in the brain is a hallmark of Alzheimer’s disease, understanding the process would allow establishing the underlying role of neuroinflammation, then estimating the prognosis of Alzheimer’s disease development and finding a new potential treatment target. In this review, we highlight the recent advances in the potential role of JAK/STAT signaling in neurological diseases with a focus on discussing future research directions regarding novel therapeutic approaches and predictive biomarkers for Alzheimer’s disease.
first_indexed 2024-03-11T09:58:03Z
format Article
id doaj.art-9742379f702044c7a2221849a2307bc9
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:58:03Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-9742379f702044c7a2221849a2307bc92023-11-16T15:39:33ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-0124186410.3390/ijms24010864The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment TargetMarta Rusek0Joanna Smith1Kamel El-Khatib2Kennedy Aikins3Stanisław J. Czuczwar4Ryszard Pluta5Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandLaboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106 Warsaw, PolandAlzheimer’s disease is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. However, emerging evidence suggests that neuroinflammation, mediated notably by activated neuroglial cells, neutrophils, and macrophages, also plays an important role in the pathogenesis of Alzheimer’s disease. Therefore, understanding the interplay between the nervous and immune systems might be the key to the prevention or delay of Alzheimer’s disease progression. One of the most important mechanisms determining gliogenic cell fate is the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway that is influenced by the overactivation of microglia and astrocytes. The JAK/STAT signaling pathway is one of the critical factors that promote neuroinflammation in neurodegenerative diseases such as Alzheimer’s disease by initiating innate immunity, orchestrating adaptive immune mechanisms, and finally, constraining neuroinflammatory response. Since a chronic neuroinflammatory environment in the brain is a hallmark of Alzheimer’s disease, understanding the process would allow establishing the underlying role of neuroinflammation, then estimating the prognosis of Alzheimer’s disease development and finding a new potential treatment target. In this review, we highlight the recent advances in the potential role of JAK/STAT signaling in neurological diseases with a focus on discussing future research directions regarding novel therapeutic approaches and predictive biomarkers for Alzheimer’s disease.https://www.mdpi.com/1422-0067/24/1/864Alzheimer’s diseaseJAK/STAT signaling pathwayneuroinflammationneuroprotectiontreatment
spellingShingle Marta Rusek
Joanna Smith
Kamel El-Khatib
Kennedy Aikins
Stanisław J. Czuczwar
Ryszard Pluta
The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
International Journal of Molecular Sciences
Alzheimer’s disease
JAK/STAT signaling pathway
neuroinflammation
neuroprotection
treatment
title The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
title_full The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
title_fullStr The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
title_full_unstemmed The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
title_short The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target
title_sort role of the jak stat signaling pathway in the pathogenesis of alzheimer s disease new potential treatment target
topic Alzheimer’s disease
JAK/STAT signaling pathway
neuroinflammation
neuroprotection
treatment
url https://www.mdpi.com/1422-0067/24/1/864
work_keys_str_mv AT martarusek theroleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT joannasmith theroleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT kamelelkhatib theroleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT kennedyaikins theroleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT stanisławjczuczwar theroleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT ryszardpluta theroleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT martarusek roleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT joannasmith roleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT kamelelkhatib roleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT kennedyaikins roleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT stanisławjczuczwar roleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget
AT ryszardpluta roleofthejakstatsignalingpathwayinthepathogenesisofalzheimersdiseasenewpotentialtreatmenttarget